Atlas Trials

Study Assessing Efficacy and Safety of NFL-101 on Reduction of Reinforcing Properties of Cigarettes (PRECESTO)

Clinical trial NCT06091826 · COMPLETED

Trial details

NCT number
NCT06091826
Sponsor
NFL Biosciences SAS
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Smoking CessationNicotine Dependence
Start date
2023-02-21
Primary completion
2023-09-15
Enrollment
34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.